Dimethyl itaconate suppresses dendritic cell and CD8+ T cell responses to halt vitiligo
Yinghan Wang, Yuhan Chen, Jingjing Ma, Linxuan Wu, Pan Kang, Jianru Chen, Pengran Du, Wei Wu, Xinju Wang, Kaiqiao He, Yuqi Yang, Sen Guo, Weinan Guo, Ling Liu, Zhe Jian, Tianwen Gao, Shuli Li, Chunying Li · 2025
Read Dimethyl itaconate suppresses dendritic cell and CD8+ T cell responses to halt vitiligo by Yinghan Wang, Yuhan Chen, Jingjing Ma, Linxuan Wu, Pan Kang, Jianru Chen, Pengran Du, Wei Wu, Xinju Wang, Kaiqiao He, Yuqi Yang, Sen Guo, Weinan Guo, Ling Liu, Zhe Jian, Tianwen Gao, Shuli Li, Chunying Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750885.txt.
Description
Yinghan Wang and co-authors test a metabolite derivative as a treatment for vitiligo, the skin condition that erases pigment. Their 2025 study starts from the disease's mechanism: immune cells destroy the pigment making cells. Few treatments target both the guiding dendritic cells and the killer T cells. Blood levels of the parent compound, itaconate, were raised in patients. Mice lacking it lost pigment faster.
The derivative, given to mice, halted the disease and restored pigment. Treated skin held more pigment cells and fewer killer T cells. The drug dulled T cell activation, attack molecules, and growth. Gene scans showed inflammatory programs turned down. Part of the effect ran through one suppressed pathway the team traced. The authors present the compound as a candidate drug hitting both arms of the attack.
Catalog record
| CREATOR | Yinghan Wang, Yuhan Chen, Jingjing Ma, Linxuan Wu, Pan Kang, Jianru Chen, Pengran Du, Wei Wu, Xinju Wang, Kaiqiao He, Yuqi Yang, Sen Guo, Weinan Guo, Ling Liu, Zhe Jian, Tianwen Gao, Shuli Li, Chunying Li |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |